To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

This study is testing the safety and effectiveness of a new drug called HD-6277 in adults with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise alone. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - Your HbA1c (a measure of average blood sugar over 3 months) is between 7.0% and 10.0% - You have been managing your diabetes with diet and exercise only (no medication) for at least 8 weeks before the study **You may NOT be eligible if...** - You have type 1 diabetes or another immune-related form of diabetes - Your BMI is above 40 kg/m² - Your C-peptide level (a marker of insulin production) is very low (below 0.5 ng/mL) Talk to your doctor to see if this trial is right for you.